Navigation Links
Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference
Date:3/28/2008

Dr. Paolo Lanzetta, investigator for a triple therapy clinical study of ranibizumab, juxtascleral triamcinolone acetonide and Visudyne; and Dr. Albert Augustin, investigator of a triple therapy clinical study of Visudyne, dexamethasone and Avastin. Dr. Lanzetta's investigator-sponsored study was supported by Novartis AG and Dr. Albert Augustin's investigator-sponsored study was funded by QLT.

The abstracts for the studies can be found in the final conference program at: http://www.maculasociety.org/annualmeeting/final_program-08.pdf

QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies. Our research and development efforts are focused on pharmaceutical products in the fields of ophthalmology and dermatology. In addition, we utilize three unique technology platforms, photodynamic therapy, Atrigel(R) and punctal plugs with drugs, to create products such as Visudyne and Eligard(R) and future product opportunities. For more information, visit our web site at http://www.qltinc.com.

Atrigel is a registered trademark of QLT USA, Inc.

Visudyne is a registered trademark of Novartis AG.

Eligard is a registered trademark of Sanofi-aventis.

QLT Inc. is listed on The NASDAQ Stock Market under the trading symbol "QLTI" and on The Toronto Stock Exchange under the trading symbol "QLT."

Certain statements contained in this press release, which are not historical facts, are "forward-looking statements," as the term is defined in the Private Securities Litigation Reform Act of 1995 and constitute "forward-looking information" within the meaning of applicable Canadian securities laws. Such forward-looking statements are predictions only and are subject to risks and uncertainties which can cause actual results to dif
'/>"/>

SOURCE QLT Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cystic Fibrosis Foundation announces positive early results for phase 2 clinical trial of VX-770
2. MRIs high false positive rate has little impact on womens choice of preventive mastectomy
3. AcroMetrix Announces Launch of First Liquid MRSA Positive Control
4. Make Your Mammogram a Positive Experience: Author Offers Guidelines and Tips to Change Womens Negative Attitudes Toward Mammograms
5. QLT announces positive FDA action on Aczone(TM)
6. Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor
7. Echo Therapeutics Announces Positive Results from Symphony(TM) Transdermal Continuous Glucose Monitoring System Study at Tufts Medical Center
8. Ibuprofen destroys aspirins positive effect on stroke risk
9. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
10. Positive results from phase 1 clinical trials of cuprindro
11. Single reader with CAD more efficient, yields fewer false positives, and possibly more sensitive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Angeles, CA (PRWEB) August 29, 2014 ... DDS, is now offering mini implants to area patients. ... permanently without worries of long-term teeth shifting and loss ... associated with full-size dental implants , their smaller ... as faster placement and easier recovery. Once placed, mini ...
(Date:8/29/2014)... 29, 2014 A home should be a safe ... unaddressed. That’s why Amica Insurance is sharing some tips to help ... suggests taking the following safety measures: , Kitchen, , ... their original containers, and keep them away from food. , ... near an exit. , Bathroom , ...
(Date:8/29/2014)... basic life support (BLS) videos available on YouTube ... guidelines, according to a new study published in ... the Australasian College for Emergency Medicine (ACEM). ... arrest are known to improve survival for,victims. , ... together the study, which reviewed educational videos from ...
(Date:8/29/2014)... New ESC registries are being launched on cardiac ... comes as the long-term phase of the cardiomyopathy ... failure patients conducted in collaboration with the Organisation ... outcomes evaluation. , The registries are all part ... Professor Roberto Ferrari, Chairperson of EORP, said: "The ...
(Date:8/29/2014)... York (PRWEB) August 29, 2014 Williams ... Micro-Needling services in their Latham aesthetic office. Dr. ... is one of the first surgeons in the area ... The innovative technique is faster and safer than ... , Micro-Needling is a noninvasive procedure , designed ...
Breaking Medicine News(10 mins):Health News:Dental Implants Dentist, Kevin Sands DDS, Is Now Offering Mini Implants 2Health News:Improve Home Safety with Tips from Amica Insurance 2Health News:New ESC registries launched on cardiac oncology and ACS 2Health News:New ESC registries launched on cardiac oncology and ACS 3Health News:New ESC registries launched on cardiac oncology and ACS 4Health News:Williams Revjuva Center Brings Micro-Needling to Latham 2
... Blue Plan Experienced a 15 Percent Increase ... a New Report from HealthLeaders-InterStudy, NASHVILLE, ... of managed care market intelligence, reports that ... medication use,through pharmacy programs and public education ...
... Health,Care Systems, Inc. (HCS), a leading provider ... medication reconciliation solutions, has entered,into an agreement with ... not-for-profit hospitals in the nation with 881 licensed,acute ... facility for The,University of Alabama at Birmingham,s Family ...
... treatment could help 3.3 million U.S. sufferers, ... Medical, Inc. today,announced that 98.4 percent of ... called Barrett,s esophagus were free of the ... the HALO ablation,system. The results were published ...
... release of milk in humans, animals , , FRIDAY, July 18 ... speaking? , Researchers have discovered that babies nursing at ... to release of oxytocin, known as the "trust" hormone in ... to be involved in trust and love in both humans ...
... restored brain,s ability to make new cells , , FRIDAY, July ... day may lead to health issues, including depression, a new ... a causal link between abstinence from alcohol drinking and depression," ... and pharmacology in the University of North Carolina School of ...
... in French . , Winnipeg (July ... Canadian Institutes of Health Research (CIHR) was announced today ... Secretary for Health, on behalf of Tony Clement, Minister ... investigating how to improve the application of mental health ...
Cached Medicine News:Health News:New York's Excellus BlueCross BlueShield to Continue Generic Medication Promotion to Help Control Costs 2Health News:Huntsville Hospital Signs With Health Care Systems, Inc. for Automated Medication Reconciliation Services 2Health News:Precancerous Esophagus Disease Eliminated in 98.4% of Patients Treated With HALO Ablation System 2Health News:Precancerous Esophagus Disease Eliminated in 98.4% of Patients Treated With HALO Ablation System 3Health News:Suckling Infant Triggers 'Trust' Hormone in Moms 2Health News:Research Finds Causal Link Between Ending Drinking, Depression 2Health News:CIHR announces $4.4 million to improve mental health of Canadians 2
(Date:8/28/2014)... , Aug. 28, 2014 Pharmatech ... two-year investment into this game-changing method for matching ... Today, clinical trials target specific cancers, disease ... contributing factors for the cancer, in the first ... that this information may not be well known ...
(Date:8/28/2014)... Aug. 28, 2014 /PRNewswire-iReach/ -- EDGE Orthopaedics, a ... is excited to announce they have received their ... System and REDUCE Fracture Plating System. ... to support multiple indications within the mid-foot. The ... Metatarsophalangeal (MTP), Calcaneal-Cuboid (CC), Talonavicular (TN) and Evans ...
(Date:8/28/2014)... China , Aug. 28, 2014 ... TPI ), a pharmaceutical company that specializes in ... generics and active pharmaceutical ingredients (API) today updates ... Company,s Qionglai Facility (QLF). The ... Practice (GMP) dataset for China Food & Drug ...
Breaking Medicine Technology:Enrollment in Pharmatech's Revolutionary AccessPPM Program Launches 2EDGE Orthopaedics Receives Second FDA Clearance 2TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2
... 23, 2011 Takeda Pharmaceutical Company Limited (Takeda) ... Center, Inc. U.S., submitted a New Drug Application ... (FDA) for an investigational fixed-dose combination of azilsartan ... hypertension, or high blood pressure. Discovered by Takeda, ...
... (Nasdaq: IDIX ), announced today that Idenix management ... Healthcare Conference on March 2, 2011 at 3:30 p.m. ET ... The live and archived webcast of the ... the Idenix Investor Center at www.idenix.com . Please log ...
Cached Medicine Technology:Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension 2Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension 3
P-Series Cystourethroscope Short Bridge, examining...
Short double-horn bridge for insertion of instruments...
Designed for accurate articulation of flexible devices....
... Used for stone manipulation and removal in the ... basket to retain its shape following extreme torsion. ... capture by allowing the basket to open at ... stone. The tipless design reduces the likelihood of ...
Medicine Products: